Enliven Therapeutics, Inc. ($ELVN)
Filing Information
| Accession Number | 0000947871-26-000637 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 17, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
281,408
Total Value
$12,668,988.16
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
10% Owner | Common Stock | โ | Jun 15, 2026 | Sale | 9,086 | $45.02 | $409,051.72 | 245,728 | Indirect | See Footnotes | View Details | |
10% Owner | Common Stock | โ | Jun 15, 2026 | Sale | 272,322 | $45.02 | $12,259,936.44 | 7,388,902 | Indirect | See Footnotes | View Details |